AVTX Rentabilitas operasi Avalo Therapeutics Inc

Logo perusahaan publik Avalo Therapeutics, Inc. (AVTX)

Avalo Therapeutics, Inc (AVTX) relies on external contractors to conduct research while maintaining strict control over trial timelines. The development of targeted antibodies to the LIGHT protein ensures niche leadership in the treatment of autoimmune pathologies. The GURU.Markets terminal displays a chart of the indicator, where the operating margin profile demonstrates profitability, and the -161961.00 mark characterizes this parameter. Production capacities are distributed between laboratories in the US and reliable CDMO partners.

Avalo Therapeutics, Inc. (AVTX): Rentabilitas dodolan operasi saka 04.07.2022 nganti 20.11.2026

Rincian metrik keuangan lan pasar Avalo Therapeutics, Inc (AVTX)

Pambiji fundamental perusahaan:avalotx.com, AVTX
Produk merek Avalo Therapeutics Inc

Analyzing the operating margin is critical for assessing the long-term sustainability of Avalo Therapeutics, Inc (AVTX). This indicator is calculated as the ratio of operating profit before taxes and interest to revenue, measuring the efficiency of the core business. By analyzing the operating margin time series, an investor can discern the company's actual ability to generate cash flow. Current price action reflects management transformation and a shift in priorities toward immunology. Growth in this metric would confirm the success of the new commercialization strategy.

Pesaing Avalo Therapeutics, Inc

ARGX (argenx N.V.) - Margin operasi|Rentabilitas dodolan operasi BioNTech Pharma BNTX|Margin dodolan operasi ABVX (ABIVAX)|Margin operasi ADMA Biologics, Inc. (ADMA)|Margin operasi PTGX (protagonist-inc.com)|IMVT: Rentabilitas dodolan miturut bathi operasi|KNSA - Rentabilitas operasi|GRFS: Rentabilitas operasi|ADPT (Adaptive Biotechnologies) - Margin dodolan operasi|Rentabilitas dodolan miturut bathi operasi CLDX|Margin dodolan operasi AUPH|BCRX (BioCryst Pharmaceuticals) - Rasio bathi operasi|Rentabilitas operasi Vera Pharma (VERA)|DNTH (Dianthus Therapeutics) - Tingkat bathi operasi|Pharvaris N.V. - Margin dodolan operasi|Tingkat bathi operasi ABCL|TRML: Margin dodolan operasi|PGEN (Precigen) - Rentabilitas dodolan miturut bathi operasi|pharming.com (PHAR) - Rentabilitas operasi|Nektar Corp (NKTR) - Margin operasi|UPB (upstreambio.com) - Margin operasi|ZBIO: Tingkat bathi operasi|Margin operasi IMNM|Rentabilitas kegiatan operasi Gossamer Bio Inc|Margin operasi KALV (KalVista Pharma)|SEPN (Septerna Pharma) - Margin bathi operasi|PVLA: Margin dodolan operasi|Margin bathi operasi SVRA|RIGL: Margin operasi|Rentabilitas dodolan miturut bathi operasi ANAB|ATXS (Astria Corp) - Margin operasi|Rentabilitas dodolan miturut bathi operasi ENGN (enGene Bio)|Margin operasi RAPT|Rentabilitas kegiatan operasi Aerovate Therapeutics|Rentabilitas operasi Aclaris Therapeutics Inc. ACRS|Rentabilitas kegiatan operasi Kyverna Therapeutics Inc. (KYTX)|TLSA - Rentabilitas operasi|CABA: Rentabilitas operasi|VTYX (Ventyx Biosciences, Inc.) - Margin dodolan operasi|THTX - Rentabilitas kegiatan operasi|ELDN (Eledon Pharmaceuticals, Inc) - Margin operasi|Rentabilitas dodolan operasi Agenus Inc. AGEN|Margin dodolan operasi CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Tingkat bathi operasi|Rentabilitas operasi atyrpharma.com ATYR|Margin operasi Adagene Corp ADAG|IMA - Rentabilitas operasi|Tingkat bathi operasi STTK (Shattuck Labs)|EQ: Margin operasi|Connect Biopharma (CNTB) - Margin operasi|Rentabilitas operasi Immunic|Margin operasi atarabio.com|Margin operasi IFRX|Margin operasi X4 Pharma (XFOR)|Margin operasi ACET (adicetbio.com)|Margin operasi Celularity Inc. CELU|INMB - Rentabilitas operasi|Tingkat bathi operasi BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Margin dodolan operasi|Margin dodolan operasi SAB Biotherapeutics Inc.|Margin dodolan operasi AKTX|Margin dodolan operasi enlivex.com (ENLV)|Rentabilitas operasi Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Tingkat bathi adhedhasar bathi operasi|Margin operasi EDSA (Edesa Biotech Corp)|Rentabilitas kegiatan operasi iBio (IBIO)|CARM - Rentabilitas operasi|XTL Biopharmaceuticals (XTLB) - Margin dodolan operasi|BOLT: Margin operasi|Margin dodolan operasi HCW Biologics Inc.|Rentabilitas operasi Aptevo|Rentabilitas dodolan miturut bathi operasi AIM (AIM ImmunoTech, Inc.)|Margin operasi ADTX|Rentabilitas kegiatan operasi GRI Bio Corp|Margin operasi XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Rentabilitas dodolan operasi|Revelation Biosciences Corp - Margin operasi|INDP (Indaptus Therapeutics, Inc.) - Rentabilitas dodolan miturut bathi operasi|SCNI: Margin operasi|CALI - Rentabilitas kegiatan operasi|AFMD (Affimed N.V.) - Margin operasi|Rentabilitas operasi ALLK|Margin dodolan operasi HOOK (HOOKIPA Pharma, Inc.)|IGMS - Rentabilitas dodolan operasi|Rentabilitas operasi iTeos ITOS|Ocean Bio - Rentabilitas operasi|TC BioPharm Ltd - Margin operasi|Rentabilitas dodolan operasi thirdharmonicbio.com